share_log

Executives Buy Around $5M Of 4 Penny Stocks

Executives Buy Around $5M Of 4 Penny Stocks

高管購買約 5 萬美元的 4 便士股票
Benzinga Real-time News ·  2022/05/09 09:18


US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.


美國原油期貨周一走低。與此同時,投資者專注於一些值得注意的內幕交易。

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

當內部人士購買或出售股票時,表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以認為這是他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out href=""> Benzinga's insider transactions platform.3

以下是最近一些細價股的著名內幕交易。欲了解更多信息,請查看 href= "" > 本辛加的內幕交易 平台 .3

Nymox Pharmaceutical

尼莫克斯製藥

  • The Trade: Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Director James G. Robinson acquired a total of 1,151,515 shares at an average price of $1.65. To acquire these shares, it cost $1.9 million.
  • What's Happening: Nymox, last month, announced closing of $6.4 million financing.
  • What Nymox Pharmaceutical Does: Nymox Pharmaceutical Corp is a biopharmaceutical company. The firm and its subsidiaries specialize in the research and development of drugs and diagnostic products for the aging population.
  • 貿易: 尼莫斯製藥股份有限公司 詹姆斯·羅賓遜董事以 1.65 美元的平均價格收購了 1,151,515 股股票。要收購這些股份,成本為 190 萬美元。
  • 發生了什麼事: Nymox 上個月宣布關閉 640 萬美元融資。
  • 尼莫克斯製藥的作用是什麼: 尼莫克斯製藥股份有限公司是一家生物製藥公司。該公司及其子公司專注於針對人口老齡化的藥物和診斷產品的研究和開發。

Alzamend Neuro

神经修正

  • The Trade: Alzamend Neuro, Inc. (NASDAQ:ALZN) 10% owner Milton C. Ault III acquired a total of 100,000 shares at an average price of $1.07. The insider spent around $106.85 thousand to buy those shares.
  • What's Happening: Alzamend Neuro reported initiation of Phase IIA multiple ascending dose clinical trial for AL001 treatment of dementia related to Alzheimer's.
  • What Alzamend Neuro Does: Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments.
  • 貿易: 神經修改, 公司. (納斯達克:阿爾贊)10% 的所有者米爾頓·奧爾特三號以 1.07 美元的平均價格獲得了總共 100,000 股。內部人士花費了大約 106.85 萬美元購買這些股票。
  • 發生了什麼:Alz修改神經報告的IIA 期多次上升劑量臨床試驗的啟動,用於治療與阿爾茨海默氏症相關的癡呆症的 AL001 治療。
  • 什麼神經確實: 神經股份有限公司是一家早期臨床階段的生物製藥公司。它專注於開發用於治療神經退行性疾病和精神疾病(包括阿爾茨海默氏症)的新穎產品。其使命是開發和銷售安全有效的治療方法。

Also check this: Executives Buy More Than $90M Of 4 Stocks

還要檢查這個:高管購買超過 9 億美元的 4 股票

Don't forget to check out our premarket coverage here .

別忘了在這裡查看我們的售前保障。

Great Elm Group

大榆集團

  • The Trade: Great Elm Group, Inc. (NASDAQ:GEG) 10% owner Long Ball Partners Llc acquired a total of 1,369,984 shares at an average price of $1.81. To acquire these shares, it cost around $2.48 million.
  • What's Happening: Great Elm Group recently posted a Q3 loss of $0.22 per share.
  • What Great Elm Group Does: Great Elm Group Inc formerly, Great Elm Capital Group Inc operates as a holding company. The company operates in four business lines including durable medical equipment, investment management and real estate with general corporate.
  • 貿易: 大榆樹集團股份有限公司 (納斯達克:GEG) 10% 所有者長球合作夥伴有限責任公司以 1.81 美元的平均價格收購了共 1,369,984 股。要收購這些股份,成本約為 248 萬元。
  • 發生了什麼: 偉大榆業集團最近公佈了第三季度虧損 0.22 美元每股。
  • 偉大的榆樹集團做了什麼: 偉大榆樹集團有限公司以前,偉大榆樹資本集團有限公司作為一家控股公司經營。該公司經營四條業務線,包括耐用的醫療設備,投資管理和一般企業的房地產。

United Health Products

聯合健康產品

  • The Trade: United Health Products, Inc. (OTC:UEEC) CEO Brian Thom acquired a total of 300,000 shares at an average price of $0.42. The insider spent $126 thousand to buy those shares.
  • What's Happening: United Health Products recently issued an update on its FDA regulatory process and other matters.
  • What United Health Products Does: United Health Products Inc is a US-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors.
  • 貿易: 聯合健康產品有限公司 OTC:UEEC)首席執行官博萊恩·湯姆以 0.42 美元的平均價格購買了共 30 萬股股票。內幕人士花了 126 萬美元購買這些股票。
  • 發生了什麼: 聯合健康產品最近發佈了其 FDA 監管程序及其他事項的最新消息。
  • 聯合健康產品的作用: 聯合健康產品公司是一家總部位於美國的公司。它主要為醫療保健和傷口護理領域生產和銷售專利止血紗布。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論